GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Polarean Imaging PLC (LSE:POLX) » Definitions » Net Cash per Share

Polarean Imaging (LSE:POLX) Net Cash per Share : £0.02 (As of Jun. 2023)


View and export this data going back to 2018. Start your Free Trial

What is Polarean Imaging Net Cash per Share?

Net Cash per Share is calculated as Cash, Cash Equivalents, Marketable Securities minus Total Liabilities minus Minority Interest and then divided by Shares Outstanding (EOP). Polarean Imaging's Net Cash per Share for the quarter that ended in Jun. 2023 was £0.02.

The historical rank and industry rank for Polarean Imaging's Net Cash per Share or its related term are showing as below:

LSE:POLX' s Price-to-Net-Cash Range Over the Past 10 Years
Min: 1.88   Med: 9.17   Max: 34
Current: 1.93

During the past 7 years, the highest Price-to-Net-Cash Ratio of Polarean Imaging was 34.00. The lowest was 1.88. And the median was 9.17.

LSE:POLX's Price-to-Net-Cash is ranked better than
88.06% of 335 companies
in the Medical Devices & Instruments industry
Industry Median: 7.02 vs LSE:POLX: 1.93

Polarean Imaging Net Cash per Share Historical Data

The historical data trend for Polarean Imaging's Net Cash per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Polarean Imaging Net Cash per Share Chart

Polarean Imaging Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22
Net Cash per Share
Get a 7-Day Free Trial -0.01 - 0.02 0.09 0.05

Polarean Imaging Semi-Annual Data
Dec16 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23
Net Cash per Share Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.12 0.09 0.07 0.05 0.02

Competitive Comparison of Polarean Imaging's Net Cash per Share

For the Medical Devices subindustry, Polarean Imaging's Price-to-Net-Cash, along with its competitors' market caps and Price-to-Net-Cash data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Polarean Imaging's Price-to-Net-Cash Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Polarean Imaging's Price-to-Net-Cash distribution charts can be found below:

* The bar in red indicates where Polarean Imaging's Price-to-Net-Cash falls into.



Polarean Imaging Net Cash per Share Calculation

In the calculation of a company's Net Cash per Share, assets other than cash and short term investments are considered to be worth nothing. But the company has to pay its debt and other liabilities in full. This is an extremely conservative way of valuation. Most companies have negative Net Cash per Share. But sometimes a company's price may be lower than its net-cash.

Polarean Imaging's Net Cash per Share for the fiscal year that ended in Dec. 2022 is calculated as

Net Cash per Share (A: Dec. 2022 )
=(Cash, Cash Equivalents, Marketable Securities-Total Liabilities-Minority Interest)/Shares Outstanding (EOP)
=(13.509-2.653-0)/213.048
=0.05

Polarean Imaging's Net Cash per Share for the quarter that ended in Jun. 2023 is calculated as

Net Cash per Share (Q: Jun. 2023 )
=(Cash, Cash Equivalents, Marketable Securities-Total Liabilities-Minority Interest)/Shares Outstanding (EOP)
=(7.825-2.62-0)/213.9
=0.02

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Polarean Imaging  (LSE:POLX) Net Cash per Share Explanation

Ben Graham invested in situations where the company's stock price was lower than its net-cash. He assigned some value to the company's other current asset. The value is called Net Current Asset Value (NCAV). One research study, covering the years 1970 through 1983 showed that portfolios picked at the beginning of each year, and held for one year, returned 29.4 percent, on average, over the 13-year period, compared to 11.5 percent for the S&P 500 Index. Other studies of Graham's strategy produced similar results.

You can find companies that are traded below their Net Current Asset Value (NCAV) with our Net-Net screener.


Polarean Imaging Net Cash per Share Related Terms

Thank you for viewing the detailed overview of Polarean Imaging's Net Cash per Share provided by GuruFocus.com. Please click on the following links to see related term pages.


Polarean Imaging (LSE:POLX) Business Description

Traded in Other Exchanges
Address
27-28 Eastcastle Street, London, GBR, W1W 8DH
Polarean Imaging PLC designs and manufactures medical drug-device combination companies operating in the high-resolution medical imaging market. Its only operating segment being the development and commercialization of gas polariser devices and ancillary instruments. Geographically, it derives most of the revenue from the United States of America and also has a presence in Canada and the United Kingdom. The company generates revenue from products and services such as Polarisers, Parts and Upgrades, Service and other revenue. Its product portfolio includes 9820 129Xe Hyperpolarizer, 9800 129Xe Hyperpolarizer, Polarean 3777 129Xe Hyperpolarizer Upgrade Module, Polarean 2881 Polarization Measurement Station, and others.

Polarean Imaging (LSE:POLX) Headlines

No Headlines